We invest in strategic research to drive innovation in diagnosis, treatments and clinical trial design for myeloma and to further our understanding of how myeloma develops and why it becomes resistant to treatments. This will help us to identify new ways to treat myeloma or to make existing treatments more effective. We are investing in research to understand how to capture and compare clinical data about myeloma to develop the evidence to drive change.
You can read more about our completed and ongoing research projects below.
